
### [MONDO:0015187](http://purl.obolibrary.org/obo/MONDO_0015187)
**Label:** rare inflammatory bowel disease

**Subclasses:** [MONDO:0015565](http://purl.obolibrary.org/obo/MONDO_0015565) (cap polyposis), [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0009051](http://purl.obolibrary.org/obo/MONDO_0009051) (cutaneous photosensitivity-lethal colitis syndrome), [MONDO:0015176](http://purl.obolibrary.org/obo/MONDO_0015176) (undetermined colitis), [MONDO:0017411](http://purl.obolibrary.org/obo/MONDO_0017411) (neonatal inflammatory skin and bowel disease), [MONDO:0016542](http://purl.obolibrary.org/obo/MONDO_0016542) (immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0013153](http://purl.obolibrary.org/obo/MONDO_0013153) (inflammatory bowel disease 28), [MONDO:0013693](http://purl.obolibrary.org/obo/MONDO_0013693) (inflammatory skin and bowel disease, neonatal, 1), [MONDO:0014481](http://purl.obolibrary.org/obo/MONDO_0014481) (inflammatory skin and bowel disease, neonatal, 2), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0012941](http://purl.obolibrary.org/obo/MONDO_0012941) (inflammatory bowel disease 25), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0018439](http://purl.obolibrary.org/obo/MONDO_0018439) (eosinophilic colitis), [MONDO:0014338](http://purl.obolibrary.org/obo/MONDO_0014338) (IL21-related infantile inflammatory bowel disease), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), 

**Mapped go classes:** [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0002757](http://purl.obolibrary.org/obo/GO_0002757) (immune response-activating signal transduction), [GO:0016175](http://purl.obolibrary.org/obo/GO_0016175) (superoxide-generating NADPH oxidase activity), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0050832](http://purl.obolibrary.org/obo/GO_0050832) (defense response to fungus), [GO:0007260](http://purl.obolibrary.org/obo/GO_0007260) (tyrosine phosphorylation of STAT protein), [GO:0005086](http://purl.obolibrary.org/obo/GO_0005086) (ARF guanyl-nucleotide exchange factor activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0045730](http://purl.obolibrary.org/obo/GO_0045730) (respiratory burst), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0045579](http://purl.obolibrary.org/obo/GO_0045579) (positive regulation of B cell differentiation), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0005126](http://purl.obolibrary.org/obo/GO_0005126) (cytokine receptor binding), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0006801](http://purl.obolibrary.org/obo/GO_0006801) (superoxide metabolic process), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0004904](http://purl.obolibrary.org/obo/GO_0004904) (interferon receptor activity), [GO:0030890](http://purl.obolibrary.org/obo/GO_0030890) (positive regulation of B cell proliferation), [GO:0002729](http://purl.obolibrary.org/obo/GO_0002729) (positive regulation of natural killer cell cytokine production), [GO:0071800](http://purl.obolibrary.org/obo/GO_0071800) (podosome assembly), [GO:0098508](http://purl.obolibrary.org/obo/GO_0098508) (endothelial to hematopoietic transition), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0005134](http://purl.obolibrary.org/obo/GO_0005134) (interleukin-2 receptor binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042554](http://purl.obolibrary.org/obo/GO_0042554) (superoxide anion generation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0032825](http://purl.obolibrary.org/obo/GO_0032825) (positive regulation of natural killer cell differentiation), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0045078](http://purl.obolibrary.org/obo/GO_0045078) (positive regulation of interferon-gamma biosynthetic process), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0004716](http://purl.obolibrary.org/obo/GO_0004716) (signal transducer, downstream of receptor, with protein tyrosine kinase activity), [GO:0032740](http://purl.obolibrary.org/obo/GO_0032740) (positive regulation of interleukin-17 production), [GO:0032587](http://purl.obolibrary.org/obo/GO_0032587) (ruffle membrane), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0035091](http://purl.obolibrary.org/obo/GO_0035091) (phosphatidylinositol binding), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0001783](http://purl.obolibrary.org/obo/GO_0001783) (B cell apoptotic process), [GO:0045954](http://purl.obolibrary.org/obo/GO_0045954) (positive regulation of natural killer cell mediated cytotoxicity), [GO:0004920](http://purl.obolibrary.org/obo/GO_0004920) (interleukin-10 receptor activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0043020](http://purl.obolibrary.org/obo/GO_0043020) (NADPH oxidase complex), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0097038](http://purl.obolibrary.org/obo/GO_0097038) (perinuclear endoplasmic reticulum), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0030235](http://purl.obolibrary.org/obo/GO_0030235) (nitric-oxide synthase regulator activity), [GO:0032733](http://purl.obolibrary.org/obo/GO_0032733) (positive regulation of interleukin-10 production), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0001819](http://purl.obolibrary.org/obo/GO_0001819) (positive regulation of cytokine production), 

**Class expressions from DL-Learner:**

- Thing 53.44%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.72%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 51.72%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.72%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.08%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 37.08%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.08%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 37.08%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 37.08%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.08%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.08%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.08%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.08%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.08%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.08%


